Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...
Less than two months after an accelerated approval from the FDA, a drug combination featuring Pfizer’s Braftovi has turned in ...
The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult pat ...
A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The battle against rectal cancer ... The FDA recognized dostarlimab’s transformative potential by granting it a "Breakthrough Therapy Designation" in December 2024. This expedited approval ...
The dye, known for its bright cherry-red color, is found in candies, snack cakes, maraschino cherries, and some beverages.
Eli Lilly’s Verzenio breast cancer drug has been approved in Europe ... However in the US it has a list price before any discounts or rebates of about $10,948 per month. Dr Arash Tahbaz ...
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's blockbuster cancer drug, Opdivo.
The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.